Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pankaj R Patel

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Bioorganic & Medicinal Chemistry Letters|July 1, 2008
Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonistBrijesh Kumar Srivastava, Rina Soni, Jayendra Z Patel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 23, 2017
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH modelsMukul R Jain, Suresh R Giri, Bibhuti Bhoi, et al.
Journal of Medicinal Chemistry|November 6, 2007
Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: synthesis, biological evaluation, and molecular modeling in the homology modelBrijesh Kumar Srivastava, Amit Joharapurkar, Saurin Raval, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2009
Hair growth stimulator property of thienyl substituted pyrazole carboxamide derivatives as a CB1 receptor antagonist with in vivo antiobesity effectBrijesh Kumar Srivastava, Rina Soni, Jayendra Z Patel, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Pharmacology Research & Perspectives|August 14, 2020
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancerKrishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2008
Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazoleBrijesh Kumar Srivastava, Rina Soni, Amit Joharapurkar, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Bioorganic & Medicinal Chemistry Letters|July 1, 2008
Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonistBrijesh Kumar Srivastava, Rina Soni, Jayendra Z Patel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 23, 2017
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH modelsMukul R Jain, Suresh R Giri, Bibhuti Bhoi, et al.
Journal of Medicinal Chemistry|November 6, 2007
Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: synthesis, biological evaluation, and molecular modeling in the homology modelBrijesh Kumar Srivastava, Amit Joharapurkar, Saurin Raval, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2009
Hair growth stimulator property of thienyl substituted pyrazole carboxamide derivatives as a CB1 receptor antagonist with in vivo antiobesity effectBrijesh Kumar Srivastava, Rina Soni, Jayendra Z Patel, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Pharmacology Research & Perspectives|August 14, 2020
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancerKrishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2008
Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazoleBrijesh Kumar Srivastava, Rina Soni, Amit Joharapurkar, et al.
Pageof 4